Therefore, our results revealed for the first time that the miR-27a-3p/Hoxa10/Kv4.3 axis is involved in the pathogenesis of myocardial hypertrophy and electrical remodeling, and these results provided a new therapeutic strategy for myocardial hypertrophy and electrical remodeling clinically. This evidence concerns the gene HOXA10 and cardiac hypertrophy.